Implementing and Maintaining PMS and Performance Evaluation under the IVDR – Webinar
Celegence - https://www.celegence.com/services/ivdr/ - is a global life science consulting firm focused solely on regulatory and quality compliance. We have the expertise to provide support for all of your In Vitro Diagnostic (IVD) regulatory needs; from strategic consulting, registration, device classification, PERs, to in country representation. The EU In Vitro Diagnostic Devices Regulation (IVDR) brings together previously disparate components of the quality system and requires them to interoperate in a highly synchronous manner with Post Market Surveillance (PMS) driving the documentation cycle for each product in a manufacturer’s portfolio. This featured presentation will be led by Celegence’s Regulatory Affairs Subject Matter Expert for Medical Devices and IVDs James Shearn. There will be a Q/A session following the presentation. Contact us at [email protected] to learn more.

IQNET Public Webinar on ISO 9001, ISO 14001, and ISO 45001 Revision

Insights from implementing an intervention for complex mental health conditions (PRIMROSE)

P2R Flexi Slot: Intro to P2R Deliverables

Navigating Clinical Evaluation Excellence: A Strategic Guide for Medical Devices - Celegence Webinar

AI + Your Team: The New In-House Billing Playbook

EU Industry Talks - EU Tech Sovereignty Package: what it means for the European industry

NIHR Health Technology Assessment (HTA) Social Care Programme Remit and Competitiveness webinar 2026

Causal Economic Evaluation via Target Trial Emulation, NIHR RSS Research Methods Academy

GFRR 2026 - From Commitment to Practice: Tools, Pilots & Accountability in Responsible Recruitment

Real-Time WebSockets Course | Build a Live Sports Dashboard with Node.js & PostgreSQL

Doctors on Doctors: An Insightful Conversation Between Dr. Lahari & Dr. Divya! | Bangalore Hospitals

Info Session: NEB Academy | Skills Infrastructure (24 June 2026)

Webinar: The countdown to health. The Ambient Air Quality Directive Transposition. 23 June, 2026.

